Dear EOTP editors,
This is a response to the problem brought to light by the authors of the A3 receptor agonist Patent.
Regarding my review, their Patent was not cited because I used only Patent Applications and not Issued Patents on my paper. This is explicit in the methodology section. By the time of my search their patent was already issued. I apologize for any inconvenient, but I opted for this in order to bring the most recent trends in the Neuropathic Pain area.
Best wishes,
Dr. Rodolfo do Couto Maia.